BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 27871039)

  • 1. Synthesis and antitumor activity of novel substituted uracil-1'(N)-acetic acid ester derivatives of 20(S)-camptothecins.
    Li DZ; Zhang QZ; Wang CY; Zhang YL; Li XY; Huang JT; Liu HY; Fu ZD; Song HX; Lin JP; Ji TF; Pan XD
    Eur J Med Chem; 2017 Jan; 125():1235-1246. PubMed ID: 27871039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facile synthesis and cytotoxicity of substituted uracil-1'(
    Li DZ; Fu ZD; Liu HY; Pan XD
    J Asian Nat Prod Res; 2024 Feb; 26(2):259-268. PubMed ID: 38347748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and cytotoxicity of novel 20-O-linked homocamptothecin ester derivatives as potent topoisomerase I inhibitors.
    Li DZ; Wang CY; Liu RH; Wang YM; Ji TF; Li YR; Pan XD
    J Asian Nat Prod Res; 2013 Nov; 15(11):1179-88. PubMed ID: 24215541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of 9-(heteroarylmethylidene)amino derivatives of homocamptothecin with biological activities.
    Guo W; Miao Z; Sheng C; Yao J; Liu W; Zhu L; Zhang Y; Cheng P; Dong G; Zhuang C; Zhang W
    Chem Biodivers; 2011 Jul; 8(7):1266-73. PubMed ID: 21766447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of novel homocamptothecins conjugating with dihydropyrimidine derivatives as potent topoisomerase I inhibitors.
    Zhu L; Cheng P; Lei N; Yao J; Sheng C; Zhuang C; Guo W; Liu W; Zhang Y; Dong G; Wang S; Miao Z; Zhang W
    Arch Pharm (Weinheim); 2011 Nov; 344(11):726-34. PubMed ID: 21956522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and antitumor activity of the hexacyclic camptothecin derivatives.
    Gao H; Zhang X; Chen Y; Shen H; Pang T; Sun J; Xu C; Ding J; Li C; Lu W
    Bioorg Med Chem Lett; 2005 Jul; 15(13):3233-6. PubMed ID: 15913996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of novel 7-acyl homocamptothecins as Topoisomerase I inhibitors.
    Liu W; Zhu L; Guo W; Zhuang C; Zhang Y; Sheng C; Cheng P; Yao J; Wang W; Dong G; Wang S; Miao Z; Zhang W
    Eur J Med Chem; 2011 Jun; 46(6):2408-14. PubMed ID: 21463912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suzuki coupling based synthesis and in vitro cytotoxic evaluation of 7-heteroaryl-substituted camptothecin analogs.
    Wang L; Huang Y; Zhang J; Tong L; Chen Y; Lu W; Huang Q
    Bioorg Med Chem Lett; 2014 Mar; 24(6):1597-9. PubMed ID: 24529870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of 7-alkenyl homocamptothecins as potent topoisomerase I inhibitors.
    Zhu L; Zhang X; Lei N; Liu W; Miao Z; Zhuang C; Sheng C; Guo W; Dong G; Yao J; Cheng P; Zhang W
    Chem Biodivers; 2012 Jun; 9(6):1084-94. PubMed ID: 22700227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and Biological Evaluation of 10-Substituted Camptothecin Derivatives with Improved Water Solubility and Activity.
    Yang XY; Zhao HY; Lei H; Yuan B; Mao S; Xin M; Zhang SQ
    ChemMedChem; 2021 Mar; 16(6):1000-1010. PubMed ID: 33241878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Synthesis and antitumor activity of 20-O-linked camptothecin ester derivatives].
    Pan XD; Liu HY; Sun PY; Zhu CG; Yang J; Yuan KH; Han R
    Yao Xue Xue Bao; 2004 Aug; 39(8):591-7. PubMed ID: 15563058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and systematic evaluation of cytotoxic 3-heteroarylisoquinolinamines as topoisomerases inhibitors.
    My Van HT; Woo H; Jeong HM; Khadka DB; Yang SH; Zhao C; Jin Y; Lee ES; Youl Lee K; Kwon Y; Cho WJ
    Eur J Med Chem; 2014 Jul; 82():181-94. PubMed ID: 24904965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview on the development of new potentially active camptothecin analogs against cancer.
    Chazin Ede L; Reis Rda R; Junior WT; Moor LF; Vasconcelos TR
    Mini Rev Med Chem; 2014; 14(12):953-62. PubMed ID: 25355593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, topoisomerase I inhibitory activity, and in vivo evaluation of 11-azacamptothecin analogs.
    Uehling DE; Nanthakumar SS; Croom D; Emerson DL; Leitner PP; Luzzio MJ; McIntyre G; Morton B; Profeta S; Sisco J
    J Med Chem; 1995 Mar; 38(7):1106-18. PubMed ID: 7707314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trifluoromethyl-promoted homocamptothecins: synthesis and biological activity.
    Zhu L; Miao Z; Sheng C; Guo W; Yao J; Liu W; Che X; Wang W; Cheng P; Zhang W
    Eur J Med Chem; 2010 Jul; 45(7):2726-32. PubMed ID: 20304538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel 7-substituted camptothecins with potent antitumor activity.
    Dallavalle S; Delsoldato T; Ferrari A; Merlini L; Penco S; Carenini N; Perego P; De Cesare M; Pratesi G; Zunino F
    J Med Chem; 2000 Oct; 43(21):3963-9. PubMed ID: 11052801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, mechanisms of action, and toxicity of novel 20(s)-sulfonylamidine derivatives of camptothecin as potent antitumor agents.
    Wang MJ; Liu YQ; Chang LC; Wang CY; Zhao YL; Zhao XB; Qian K; Nan X; Yang L; Yang XM; Hung HY; Yang JS; Kuo DH; Goto M; Morris-Natschke SL; Pan SL; Teng CM; Kuo SC; Wu TS; Wu YC; Lee KH
    J Med Chem; 2014 Jul; 57(14):6008-18. PubMed ID: 25003995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel 7-oxyiminomethyl derivatives of camptothecin with potent in vitro and in vivo antitumor activity.
    Dallavalle S; Ferrari A; Biasotti B; Merlini L; Penco S; Gallo G; Marzi M; Tinti MO; Martinelli R; Pisano C; Carminati P; Carenini N; Beretta G; Perego P; De Cesare M; Pratesi G; Zunino F
    J Med Chem; 2001 Sep; 44(20):3264-74. PubMed ID: 11563925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of novel benzoxanthone analogues as non-Camptothecin topoisomerase I inhibitors.
    Cheng P; Zhu L; Guo W; Liu W; Yao J; Dong G; Zhang Y; Zhuang C; Sheng C; Miao Z; Zhang W
    J Enzyme Inhib Med Chem; 2012 Jun; 27(3):437-42. PubMed ID: 21770860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hybrid topoisomerase I and HDAC inhibitors as dual action anticancer agents.
    Cincinelli R; Musso L; Artali R; Guglielmi MB; La Porta I; Melito C; Colelli F; Cardile F; Signorino G; Fucci A; Frusciante M; Pisano C; Dallavalle S
    PLoS One; 2018; 13(10):e0205018. PubMed ID: 30300374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.